The new trend of listed companies that wink at environmental organizations and talk about a combination of profitability and concern for the environment, society and corporate governance (ESG) is reaching
nature
-2.7%
Base:3,700
opening:3,695
Tall:3,747
low:3,584
change:55,171,335
Page Quote News Graphs Company Profile Recommendations
More articles on the subject:
. The company announces that it too is setting itself goals in the field.
The company said in a statement that “these environmental sustainability commitments are aligned with three focus areas identified during the ESG’s recently completed material analysis, which contributed to the development of our renewed strategy.” And waste.
In a slightly less vague and more concrete wayBy 2030, the company is committed to reducing greenhouse gas (GHG) emissions in category 1 and 2 by 33% compared to 2017 levels, improving transparency in category 3 greenhouse gas emissions and increasing climate involvement with key suppliers, increasing energy efficiency in 10% and the rate of energy purchased or produced from renewable sources by 50%, reduce the overall use of water by 10% in areas expected to be in water shortage, assess and minimize the environmental impact of pharmaceutical components used in operation, reduce the total amount of secondary packaging materials And tertiary units per batch unit and increase the proportion of recycled and responsibly purchased materials by 10%, assess the impact on the environmental life cycle of key products, continue to minimize waste from operation and the environmental impact of disposal and meet AMR Industry Alliance’s existing commitments to minimize microbial excretion. Supply.
Teva also announces the improvement of its reporting by adapting reporting to international standards, including the Global Reporting Initiative (GRI), the Sustainable Accounting Standards Board (SASB) and the Climate Change Task Force (TCFD).
Sustainalytics ranked Teva in the top 10% among pharmaceutical companies and gave the company a score of “environmental over-performance”. The company’s performance in the Dow Jones Sustainability Index has also improved from the 55th to 70th percentile in the industry in the past year. At the same time, its climate change score on CDP has improved from B to A in the past year, ranking Teva among 38% of the leading companies.
The company received a silver medal from EcoVadis, placing it in the top 23% among pharmaceutical companies in 2020.
Eric Drapa, Senior Vice President of Global Operations in Nature: “The goals are challenging but achievable, especially given the size and complexity of Teva’s global operations. With over 60 manufacturing sites in many countries, we understand the significant impact we can have on the planet. We are already – and want to remain – leaders in our industry in terms of environmental performance. “We continue to monitor our progress and from time to time re-evaluate our goals in order to continue to challenge ourselves.”
Comments on the article(0):
Your response has been received and will be published subject to system policies.
Thanks.
For a new response
Your response was not sent due to a communication problem, please try again.
Return to comment